Beyond the panacea: addressing the systemic failure in midlife female sexual health.

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY
Przeglad Menopauzalny Pub Date : 2026-06-01 Epub Date: 2026-09-25 DOI:10.5114/pm.2026.164976
Mariam Sherif, Panayoti Bachkangi
{"title":"Beyond the panacea: addressing the systemic failure in midlife female sexual health.","authors":"Mariam Sherif, Panayoti Bachkangi","doi":"10.5114/pm.2026.164976","DOIUrl":null,"url":null,"abstract":"<p><p>Menopause is a universal midlife transition that profoundly impacts physical, psychological, and sexual wellbeing. In recent years, clinical and public attention has increasingly focused on post-reproductive health, with hormone replacement therapy and targeted symptom management gaining renewed prominence. While a growing array of evidence-based treatment options now exists to address vasomotor, mood, and sexual health concerns, the rapid expansion of therapeutic availability has introduced new clinical challenges. The democratisation of sexual and menopausal health information, though valuable in reducing stigma, has paradoxically decoupled patient expectations from clinical complexity. This review critically examines how digital marketing, social media amplification, and consumer-driven demand increasingly curate diagnostic conclusions before the clinical encounter begins. We demonstrate that these structural pressures, compounded by time-constrained consultations and cognitive heuristics, foster a culture of therapeutic shortcutting - most notably through the premature escalation to testosterone therapy for hypoactive sexual desire disorder. By synthesising evidence on clinical inertia, commercial determinants of health, and diagnostic attribution bias, we argue that current practice frequently bypasses rigorous biopsychosocial assessment, reducing multifactorial symptoms to simplistic hormonal narratives. We contextualise this trend within the regulatory precedent of the mid-urethral tape controversy, warning that unchecked diagnostic expansion risks triggering a blunt-instrument regulatory overcorrection that would indiscriminately restrict access to evidence-based therapies. Ultimately, we advocate for a deliberate return to ethical, humanistic gatekeeping. Clinicians must reclaim the consultation as a deliberative, evidence-based encounter: treating the patient not as a product of commercial demand, but as a whole person navigating a complex physiological and psychosocial transition.</p>","PeriodicalId":55643,"journal":{"name":"Przeglad Menopauzalny","volume":"25 2","pages":"123-128"},"PeriodicalIF":2.2000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13659210/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad Menopauzalny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pm.2026.164976","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Menopause is a universal midlife transition that profoundly impacts physical, psychological, and sexual wellbeing. In recent years, clinical and public attention has increasingly focused on post-reproductive health, with hormone replacement therapy and targeted symptom management gaining renewed prominence. While a growing array of evidence-based treatment options now exists to address vasomotor, mood, and sexual health concerns, the rapid expansion of therapeutic availability has introduced new clinical challenges. The democratisation of sexual and menopausal health information, though valuable in reducing stigma, has paradoxically decoupled patient expectations from clinical complexity. This review critically examines how digital marketing, social media amplification, and consumer-driven demand increasingly curate diagnostic conclusions before the clinical encounter begins. We demonstrate that these structural pressures, compounded by time-constrained consultations and cognitive heuristics, foster a culture of therapeutic shortcutting - most notably through the premature escalation to testosterone therapy for hypoactive sexual desire disorder. By synthesising evidence on clinical inertia, commercial determinants of health, and diagnostic attribution bias, we argue that current practice frequently bypasses rigorous biopsychosocial assessment, reducing multifactorial symptoms to simplistic hormonal narratives. We contextualise this trend within the regulatory precedent of the mid-urethral tape controversy, warning that unchecked diagnostic expansion risks triggering a blunt-instrument regulatory overcorrection that would indiscriminately restrict access to evidence-based therapies. Ultimately, we advocate for a deliberate return to ethical, humanistic gatekeeping. Clinicians must reclaim the consultation as a deliberative, evidence-based encounter: treating the patient not as a product of commercial demand, but as a whole person navigating a complex physiological and psychosocial transition.

在灵丹妙药之外:解决中年女性性健康的系统性失败。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Przeglad Menopauzalny
Przeglad Menopauzalny OBSTETRICS & GYNECOLOGY-
CiteScore
3.40
自引率
11.10%
发文量
32
审稿时长
6-12 weeks
期刊介绍: Menopausal Review is a scientific bimonthly aimed at gynecologists and endocrinologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书